(Q36760789)

16 August 2017

1 reference

title

The introduction of new vaccines into developing countries. IV: Global Access Strategies (English)

1 reference

16 August 2017

3

John D Clemens

1 reference

16 August 2017

4

Roy Curtiss

1 reference

16 August 2017

Richard T Mahoney

1

1 reference

16 August 2017

Anatole Krattiger

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

7 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

25

1 reference

16 August 2017

issue

20

1 reference

16 August 2017

page(s)

4003-4011

1 reference

The introduction of new vaccines into developing countries.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.047

The introduction of new vaccines into developing countries II. Vaccine financing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.047

The introduction of new vaccines into developing countries. III. The role of intellectual property

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.047

Pneumococcal vaccination in developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.047

Vaccines for otitis media: proposals for overcoming obstacles to progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.047

Pneumococcal vaccination in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.047

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.047

Health Innovation Networks to Help Developing Countries Address Neglected Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.047

Risks in new drug development: approval success rates for investigational drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.047

Cost of plasma-derived hepatitis B vaccine production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.047

Virtual drug discovery and development for neglected diseases through public-private partnerships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.047

Impact of dengue/dengue hemorrhagic fever on the developing world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.047

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.02.047

1 reference

16 August 2017

1 reference